A novel melphalan polymeric prodrug: Preparation and property study

Carbohydrate Polymers

Volumn 111, Issue , 2014, Pages 928-935

  Li, Dan ^a   Lu, Bo ^a   Huang, Zhijun ^a   Xu, Peihu ^a   Zheng, Hua ^a   Yin, Yihua ^a   Xu, Haixing ^a   Liu, Xia ^a   Chen, Lingyun ^b   Lou, Yiceng ^a   Zhang, Xueqiong ^a   Xiong, Fuliang ^a  

^a WUHAN UNIVERSITY OF TECHNOLOGY   (China)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Carboxymethyl chitosan; Cathepsin X; Melphalan; Nanoparticles

Indexed keywords

CHITOSAN; CYTOTOXICITY; NANOPARTICLES; PEPTIDES; SOLUBILITY;

CARBOXYMETHYL CHITOSAN; CATHEPSIN X; CLINICAL APPLICATION; DRUG RELEASE PROPERTIES; MELPHALAN; N-CARBOXYMETHYL CHITOSANS; POLYMERIC PRODRUGS; WATER SOLUBILITIES;

POLYMERS;

ANTINEOPLASTIC AGENT; CHITOSAN; DRUG CARRIER; GLYCYLGLYCINE; MELPHALAN; NANOPARTICLE; O,N-CARBOXYMETHYLCHITOSAN; POLYMER; PRODRUG;

CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; MULTIPLE MYELOMA; SOLUBILITY; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DRUG CARRIERS; GLYCYLGLYCINE; HUMANS; MELPHALAN; MULTIPLE MYELOMA; NANOPARTICLES; POLYMERS; PRODRUGS; SOLUBILITY;

EID: 84902306100     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.04.062     Document Type: Article

References (34)

1. A. Anitha, S. Maya, N. Deepa, K.P. Chennazhi, S.V. Nair, H. Tamura, and R. Jayakumar Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells Carbohydrate Polymers 83 2 2011 452 461
2. L. Bildstein, C. Dubernet, and P. Couvreur Prodrug-based intracellular delivery of anticancer agents Advanced Drug Delivery Reviews 63 1-2 2011 3 23
3. P.J. Burke, B.E. Toki, D.W. Meyer, J.B. Miyamoto, K.M. Kissler, M. Anderson, P.D. Senter, and S.C. Jeffrey Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl- amine linker system Bioorganic Medicinal Chemistry Letters 19 10 2009 2650 2653
4. S. Cammas, K. Suzuki, C. Sone, Y. Sakurai, K. Kataoka, and T. Okano Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers Journal of Controlled Release 48 2-3 1997 157 164 (Pubitemid 27401974)
5. B.S. Chhikara, D. Mandal, and K. Parang Synthesis and evaluation of fatty acyl ester derivatives of cytarabine as anti-leukemia agents European Journal of Medicinal Chemistry 45 10 2010 4601 4608
6. K. Chrzanowski, A. Bielawska, and J. Pałka Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells Il Farmaco 58 11 2003 1113 1119 (Pubitemid 37323930)
7. G. Devanathan, J.L. Turnbull, E. Ziomek, E.O. Purisima, R. Ménard, and T. Sulea Carboxy-monopeptidase substrate specificity of human cathepsin X Biochemical and Biophysical Research Communications 329 2 2005 445 452 (Pubitemid 40311765)
8. N. Dinauer, S. Balthasar, C. Weber, J. Kreuter, K. Langer, and H. Von Briesen Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes Biomaterials 26 29 2005 5898 5906 (Pubitemid 40803459)
9. Ö. Hjertner, M. Börset, and A. Waage Comparison of the effects of 2-chlorodeoxyadenosine and melphalan on myeloma cell lines Leukemia Research 20 2 1996 155 160 (Pubitemid 26107314)
10. K. Jain, P. Kesharwani, U. Gupta, and N.K. Jain A review of glycosylated carriers for drug delivery Biomaterials 33 16 2012 4166 4186
11. S.C. Jeffrey, M.T. Nguyen, J.B. Andreyka, D.L. Meyer, S.O. Doronina, and P.D. Senter Dipeptide-based highly potent doxorubicin antibody conjugates Bioorganic & Medicinal Chemistry Letters 16 2 2006 358 362 (Pubitemid 41680627)
12. P. Jie, S.S. Venkatraman, F. Min, B.Y.C. Freddy, and G.L. Huat Micelle-like nanoparticles of star-branched PEO-PLA copolymers as chemotherapeutic carrier Journal of Controlled Release 110 1 2005 20 33 (Pubitemid 41713928)
13. S. Juan, and M.D. Bonifacino Current protocols in cell biology 2009 John Wiley Sons, Inc. Bethesda, Maryland 3.6.1 3.6.4
14. H. Kirschke Cathepsin X 2007 Elsevier Bergholz-Rehbrücke, Germany 1 6
15. L. Liang, S. Lin, W. Dai, J. Lu, T. Yang, Y. Xiang, Y. Zhang, R. Li, and Q. Zhang Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity Journal of Controlled Release 160 3 2012 618 629
16. S. Machana, N. Weerapreeyakul, S. Barusrux, K. Thumanu, and W. Tanthanuch FTIR microspectroscopy discriminates anticancer action on human leukemic cells by extracts of Pinus kesiya; Cratoxylum formosum ssp. pruniflorum and melphalan Talanta 93 2012 371 382
17. A. Mahindra, T. Hideshima, and K.C. Anderson Multiple myeloma: Biology of the disease Blood Reviews 24 Suppl 1 2010 S5 S11
18. Z. Mao, L. Ma, J. Zhou, C. Gao, and J. Shen Bioactive thin film of acidic fibroblast growth factor fabricated by layer-by-layer assembly Bioconjugate Chemistry 16 5 2005 1316 1322 (Pubitemid 41368136)
19. D.J. Mincher, E. Van Valckenborgh, L. Young, A. Turnbull, A. Di Salvo, and K. Vanderkerken Design of mechanisms of selective prodrug activation in the bone marrow microenvironment of experimental and human multiple myeloma European Journal of Cancer Supplements 6 9 2008 26
20. D.K. Nägler, and R. Ménard Human cathepsin X: A novel cysteine protease of the papain family with a very short proregion and unique insertions FEBS Letters 434 1-2 1998 135 139 (Pubitemid 28404676)
21. D.K. Nägler, R. Zhang, W. Tam, T. Sulea, E.O. Purisima, and R. Ménard Human Cathepsin X: A cysteine protease with unique carboxypeptidase activity Biochemistry 38 39 1999 12648 12654
22. N. Obermajer, B. Doljak, P. Jamnik, U.P. Fonović, and J. Kos Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells International Journal of Biochemistry & Cell Biology 41 8-9 2009 1685 1696
23. C.M. Ofner III, K. Pica, B.J. Bowman, and C. Chen Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates International Journal of Pharmaceutics 308 1-2 2006 90 99 (Pubitemid 43097239)
24. S. Parekh, M.A. Weniger, and A. Wiestner New molecular targets in mantle cell lymphoma Seminars in Cancer Biology 21 5 2011 335 346
25. M.G. Paulick, and M. Bogyo Development of activity-based probes for cathepsin X ACS Chemical Biology 6 6 2011 563 572
26. F. Pinguet, J.M. Joulia, P. Martel, P.Y. Grosse, C. Astre, and F. Bressolle High-performance liquid chromatographic assay for melphalan in human plasma application to pharmacokinetic studies Journal of Chromatography B: Biomedical Sciences and Applications 686 1 1996 43 49 (Pubitemid 26382457)
27. P. Rajpoot, V. Bali, and K. Pathak Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan International Journal of Pharmaceutics 426 1-2 2012 219 230
28. D. Ruth, C.H. Isabella, J.Y. Harold, A.F. Pauline, U. Karel, S. Vladimir, and S. Jiri Macromolecular prodrugs for use in targeted cancer chemotherapy: Melphalan covalently coupled to N-(2-hydroxypropyl) methacrylamide copolymers Journal of Controlled Release 16 1991 121 136
29. W. She, K. Luo, C. Zhang, G. Wang, Y. Geng, L. Li, B. He, and Z. Gu The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy Biomaterials 34 5 2013 1613 1623
30. L. Sun, Y. Zhao, X. Li, H. Yuan, A. Cheng, and H. Lou A lysosomal-mitochondrial death pathway is induced by solamargine in human K562 leukemia cells Toxicology in Vitro 24 6 2010 1504 1511
31. Vig, B. S., Huttunen, K. M., Laine, K., & Rautio, J. (in press). Amino acids as promoieties in prodrug design and development. Advanced Drug Delivery Reviews. 65 (10), 2013, 1370-1385.
32. M. Wickström, K. Viktorsson, L. Lundholm, R. Aesoy, H. Nygren, L. Sooman, M. Fryknäs, L.K. Vogel, R. Lewensohn, R. Larsson, and J. Gullbo The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan Biochemical Pharmacology 79 9 2010 1281 1290
33. Z. Wu, A. Shah, N. Patel, and X. Yuan Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells Bioorganic & Medicinal Chemistry Letters 20 17 2010 5108 5112
34. H. Zheng, Y. Rao, Y. Yin, X. Xiong, P. Xu, and B. Lu Preparation, characterization, and in vitro drug release behavior of 6-mercaptopurine- carboxymethyl chitosan Carbohydrate Polymers 83 4 2011 1952 1958